Therefore, the interaction between FOXL2 alterations and the TGF-β superfamily signaling pathway will help understand the pathogenesis of ovarian tumors and design novel therapeutic strategies, especially in this particular histological subtype. The gene discussed is TGFB1; the disease is ovarian neoplasm.